Webinar: Entrepreneurial and Product Development Support for Academic and Small Business Innovators - CIMIT MAIN

Responsive Image
The FDA has approved the first rapid hepatitis C virus test for the U.S. market that can be used in patient care settings. The test, which was validated in part by the NIH RADx Tech program with funding from CDC, can provide results in about one hour, meaning patients with a positive test can begin treatment right away. We're honored to have been a part of the journey behind this important milestone! 

Learn more about this game changer for hepatitis C diagnosis >

Programs and Offerings

News and Events

null Webinar: Entrepreneurial and Product Development Support for Academic and Small Business Innovators

thumbnail

Webinar: Entrepreneurial and Product Development support for Academic and Small business Innovators

Are you a research entrepreneur or small business focused on translational science?

Join the National Center for Advancing Translational Sciences (NCATS), the National Heart, Lung, and Blood Institute (NHLBI), the National Institute on Aging (NIA) and the National Cancer Insitute (NCI) in collaboration with Wisconsin’s Center for Technology Commercialization and BioForward’s Women in Biohealth for a webinar on small business funding opportunities on Wednesday, August 30, 2023 from 1:00 – 2:30 p.m. ET.

Learn more about non-dilutive Small Business Innovation Research and Small Business Technology Transfer (SBIR/STTR) funding and resources to help small businesses advance and commercialize promising research technologies. You’ll learn about NCATS, NHLBI, NIA & NCI key research focus areas, tips for submitting a successful application, upcoming funding opportunities and other specific resources and programs for researchers and entrepreneurs. You can ask questions during a dedicated Q&A session.

 

Register >> 

Connect with Us

Our Lasting Impact

As an early pioneer in managing translational research, Cimit has directly supported over 1,200 innovator teams and reviewed or consulted on over 5,000 ideas since our founding in 1998.

We work collaboratively with healthtech innovators, entrepreneurs, and institutions to ultimately make a positive impact on patient care across the globe. We streamline pathways to progress through our efficient processes, established systems, and unparalleled market expertise.